Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1985 Jun;48(3):713-9.
doi: 10.1128/iai.48.3.713-719.1985.

Complement activation and attack on autologous cell membranes induced by streptolysin-O

Complement activation and attack on autologous cell membranes induced by streptolysin-O

S Bhakdi et al. Infect Immun. 1985 Jun.

Abstract

Streptolysin-O damages mammalian membranes through generation of large transmembrane channels formed by membrane-inserted polymers of the toxin (S. Bhakdi et al., Infect. Immun. 47:52-60, 1985). We here report that the native toxin binds naturally occurring human serum immunoglobulin G antibodies to form immune complexes with potent complement-activating capacity. Nanomolar concentrations of toxin added to antibody-containing serum cause rapid consumption of C4 and C5 hemolytic activity and 30 to 90% C3 conversion within 10 to 60 min at 37 degrees C. After binding to target membranes, streptolysin-O polymers serve as foci for antibody-dependent complement activation, which proceeds to completion with the formation of terminal C5b-9 complexes on the autologous cells. The binding and insertion of a primarily water-soluble bacterial product into a host cell membrane has thus been shown to generate a stable and hyperactive focus for activation of and self-attack by the complement system. We suggest that this process perpetuates local tissue damage, deviates host complement action away from the invading bacteria, and may possibly play a role in the pathogenesis of poststreptococcal disease.

PubMed Disclaimer

References

    1. Infect Immun. 1974 Jun;9(6):1022-7 - PubMed
    1. J Exp Med. 1971 Sep 1;134(3 Pt 2):180s-192s - PubMed
    1. Adv Immunol. 1978;26:1-53 - PubMed
    1. Proc Natl Acad Sci U S A. 1979 Nov;76(11):5867-71 - PubMed
    1. Pharmacol Ther. 1980;11(3):661-717 - PubMed

Publication types

MeSH terms

LinkOut - more resources